CClinicalTrials.gg
Status unknownNCT02199639ibHEroUpdated Apr 30, 2015

Transcultural Multidisciplinary Evaluation of Patients With Hemophili

An observational study in Patients With Haemophilia, sponsored by Universidad Católica San Antonio de Murcia. Status unknown at 1 site in Spain. Open to male participants aged 6 Years to 65 Years. Per ClinicalTrials.gov, last updated 2015-04-30.

Sponsored by Universidad Católica San Antonio de Murcia · Observational

The sponsor has not verified this record recently (last verified Mar 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
6 Years to 65 Years
Sex
Male
01

Study summary

Multidisciplinary evaluation of patients with hemophilia Spain, El Salvador and Bolivia. It aims to analyze and evaluate the skeletal muscle of patients affected with hemophilia Spain, El Salvador and Bolivia; describe deficit mobility and muscular strength, depending on the degree of injury, age, presence of inhibitors and the development of physical activity; identify the relationship between the functional deficit by clinical assessment performed with the use of validated measurement scales, the assessment of the degree of injury to specific scales of hemophilia; detect biomechanical alterations of the lower limbs and their impact on gait in patients with hemophilia; and evaluate the factors that influence the perception of illness and quality of life of patients with hemophilia.

Read the detailed description

Descriptive study of joint involvement in patients with hemophilia Spain, El Salvador and Bolivia.

Descriptive study of abnormal joint mobility and muscle strength as a result of acute conditions or the development of chronic articular sequelae.

Descriptive study of biomechanical changes in lower limb joints and their impact on gait in patients with hemophilia.

Descriptive study of the overall articular involvement (crepitus, pain, biomechanical and functional changes) in patients with hemophilia.

Descriptive study of the relationship between skeletal muscle pathology in patients with hemophilia and their perception of it, and their quality of life.

02

Conditions studied

  • Patients With Haemophilia

Browse trials for

Keywords

  • Haemophilia
  • Arthropathy
  • Range of Movement
  • Strength
  • Proprioception
  • Gait
  • Quality of Life
03

In context

Hemophilia A

866 studies on the registry are indexed under Hemophilia A; 137 are open to participants now.

This study's planned enrollment of 100 is above the median of 80 across 314 observational studies indexed under Hemophilia A.

Browse Hemophilia A studies →

Lead sponsor

Universidad Católica San Antonio de Murcia is the lead sponsor of 132 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with haemophilia from Spain, El Salvador and Bolivia

Inclusion criteria

  • Patients with hemophilia A and B.
  • Patients of all ages (pediatric, adolescents, youth and adults).
  • With or without joint involvement clinically diagnosed, and with or without a previous history of hemarthrosis joint load legs.
  • Patients with or without inhibitors.

Exclusion criteria

Exclusion Criteria:

  • Patients without prior ambulation capacity.
  • Patients diagnosed with other congenital coagulopathy (von Willebrand disease, etc..).
  • Patients with neurological or cognitive impairments that prevent understanding the questionnaires and physical tests.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Spain

    Group of patients with hemophilia recruited in the Region of Murcia (Spain) and evaluated in the Universidad Católica San Antonio between June and July 2014.

  • El Salvador

    Group of patients with hemophilia recruited in the city of San Salvador (El Salvador) and evaluated in the Hospital Nacional Rosales and the Hospital Nacional de niños "Benjamín Bloom" from San Salvador in April 2014.

  • Bolivia

    Group of patients with hemophilia recruited in the city of Santa Cruz (Bolivia) and evaluated at the Hospital Nacional de niños in Santa Cruz August 2014.

06

What researchers measure

Primary outcomes

  1. Assessment of range of motion of elbow, knee and ankle

    We will use a goniometric evaluation, along the lines indicated by Querol for assessing the range of motion in patients with hemophilia

    Time frame: Screening visit

  2. Assessment of muscle strength of arm, thigh and leg

    We will use a measure of muscular balance with the guidelines outlined by Daniels, with the adaptation of Querol for assessing muscle strength in patients with hemophilia

    Time frame: Screening visit

  3. Assessment of perception of joint pain

    We will use the visual analogue scale (VAS) for the assessment of joint pain in patients with hemophilia, with a scale from 0 (no pain) to 10 (maximum pain).

    Time frame: Screening visit

  4. Assessment of the status joint

    We will use the specific questionnaire haemophilia: Haemophilia Joint Healts Score (HJHS) for the assessment of joint status

    Time frame: Screening visit

  5. Evaluation of the performance of activities of daily living

    We will use the questionnaire Haemophilia Activities List (HAL), specific for patients with hemophilia

    Time frame: Screening visit

  6. Assessment of physical performance of patients with hemophilia

    We will use the Physical Functioning scale (HEP-Test-Q), specific for patients with hemophilia

    Time frame: Screening visit

  7. Assessment of personality traits of children

    We will use the questionnaire Eysenck Personality Questionnaire Junior (EPQJ)

    Time frame: Screening visit

  8. Evaluation of perceived quality of life for patients with hemophilia

    We will use the Hemophilia-QoL and the Child Health and Illness Profile (CHIP-CE) questionnaires for children; and the Hemophilia-QoL and A36 and 36 Health Survey (SF36) questionnairesfor adults .

    Time frame: Screening visit

Secondary outcomes

  1. Clinical variables of patients with hemophilia

    Age (years); weight (kg); Size (cm); type of haemophilia (A or B); severity of hemophilia (severe / moderate / mild); pharmacological treatment (prophylactic / on demand); presence of inhibitors; central venous catheter; family history of hemophilia; hemarthrosis in the last month; arthropathy diagnosed in some joint; use of orthoses

    Time frame: Screening visit

  2. Socio-demographic variables of patients with hemophilia

    Number of hospital visits per year (reason); Distance to hospital (km); Academic formation of the patient (university studies / vocational training / basic studies / no studies); academic formation of the parents (university studies / vocational training / basic studies / no studies); patient employment (self-employment / employment has as an employed person / unemployed / retirement); parents employment (self-employment / employment has as an employed person / unemployed / retirement);

    Time frame: Screening visit

07

Study locations

1 of 1 sites recruiting
  • Universidad Católica San Antonio de Murcia
    Murcia, 30107, Spain
    • RUBÉN CUESTA-BARRIUSO, PhD · Contact · ruben.cuestab@gmail.com · 968278806
    • ANA TORRES-ORTUÑO, PhD · Contact · atorres.ortuno@gmail.com · 968278806
    • RUBÉN CUESTA-BARRIUSO, PhD · Principal investigator
    • ANA TORRES-ORTUÑO, PhD · Principal investigator
    • JOAQUÍN NIETO-MUNUERA, PhD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02199639
Lead sponsor
Universidad Católica San Antonio de Murcia
Responsible party
RUBÉN CUESTA-BARRIUSO (PhD, Universidad Católica San Antonio de Murcia) — Principal investigator
First posted
Jul 24, 2014
Start date
Mar 2014
Primary completion
Aug 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Apr 30, 2015

Study contacts

RUBÉN CUESTA-BARRIUSO, PhD
Contact
ruben.cuestab@gmail.com
968278806
RUBEN CUESTA-BARRIUSO, PhD
principal investigator · Universidad Católica San Antonio

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion